We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Implantable Neural Interface Undergoes First Real-World Surgical Validation

By HospiMedica International staff writers
Posted on 27 Jul 2026

ABILITY Neurotech has initiated first-in-human evaluation of its fully implantable brain-computer interface (BCI) at the Department of Neurosurgery, Technical University of Munich (TUM) University Hospital Rechts der Isar. More...

The intraoperative study marks the first real-world validation of the platform’s neural signal acquisition in a live surgical setting. 

Up to five individuals undergoing brain tumor surgery will participate, with 20–30 minutes of intraoperative recording per patient. Initial cases completed end-to-end system validation and signal capture while patients were under general anesthesia. The next phase will assess neural decoding under similar conditions in conscious participants performing speech and motor tasks.

The platform is designed to capture raw, high‑resolution brain signals and to transmit massive amounts of lossless data at bandwidths significantly higher than standard Bluetooth‑based approaches. Its minimally invasive, patient‑centric architecture is engineered for long‑term implantation while maintaining high‑fidelity signal quality. A data‑first design enables continuous streaming that preserves the full content of neural recordings in a fully implantable optical brain‑computer interface.

Conducted at one of Europe’s leading neurosurgery departments, the project marks the company’s formal entry into the clinical stage. The initial dataset generated from these procedures establishes human validation of signal acquisition for the platform. The company indicates this early feasibility work will be followed by its first long‑term implantation study.

“This procedure, recording neural data from humans for the first time, is a key milestone for ABILITY and our mission to enable safe and ethical long-term BCI implantations. The real-world validation of our signal acquisition system to capture high-quality neural data in patients brings us another step closer to restoring communication, movement and autonomy for those living with paralysis and speech loss,” said Rotem Kopel, PhD, CEO of ABILITY Neurotech.

“This research allows us to capture known neural phenomena, including evoked potentials and high-gamma activity, and benchmark ABILITY's signal quality against established clinical electrophysiology systems. Establishing this scientific basis is what will allow brain-computer interface technology to mature responsibly from research into a reliable clinical tool,” said Simon Jacob, MD, Professor of Translational Neurotechnology at the Department of Neurosurgery of TUM University Hospital Rechts der Isar.

Related Links
ABILITY Neurotech
TUM University Hospital Rechts der Isar


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: iStock

Updated Head Injury Guidelines Support Risk-Based CT and Observation Decisions

Head injuries are a common reason for emergency department visits, with most cases classified as mild. However, clinicians must identify patients at risk of intracranial bleeding or other serious injuries... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.